BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32229681)

  • 1. Evaluation of the training program for p16/ Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry.
    Prevodnik VK; Marinsek ZP; Zalar J; Rozina H; Kotnik N; Jerman T; Varl J; Ivanus U
    Radiol Oncol; 2020 Mar; 54(2):201-208. PubMed ID: 32229681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears.
    Kloboves Prevodnik V; Jerman T; Nolde N; Repše Fokter A; Jezeršek S; Pohar Marinšek Ž; Klopčič U; Hutter Čelik S; Gornik Kramberger K; Primic Žakelj M; Ivanuš U
    Diagn Pathol; 2019 May; 14(1):48. PubMed ID: 31122253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
    Wentzensen N; Fetterman B; Tokugawa D; Schiffman M; Castle PE; Wood SN; Stiemerling E; Poitras N; Lorey T; Kinney W
    Cancer Cytopathol; 2014 Dec; 122(12):914-20. PubMed ID: 25132656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
    Prigenzi KCK; Heinke T; Salim RC; Focchi GRA
    Acta Cytol; 2018; 62(2):104-114. PubMed ID: 29566392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
    Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
    Celewicz A; Celewicz M; Wężowska M; Chudecka-Głaz A; Menkiszak J; Urasińska E
    Pol J Pathol; 2018; 69(1):42-47. PubMed ID: 29895125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
    Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of p16/Ki-67 immunocytochemical dual staining in cervical cancer screening].
    Wang HR; Liao GD; Chen W; Qiao YL; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):636-640. PubMed ID: 28835090
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
    J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-tiered score for Ki-67 and p16
    van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
    J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
    Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
    Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver reproducibility in determining p16 overexpression in cervical lesions : use of a combined scoring method.
    Vinyuvat S; Karalak A; Suthipintawong C; Tungsinmunkong K; Kleebkaow P; Trivijitsilp P; Siriaunkgul S; Triratanachat S; Khunamornpong S; Chuangsuwanich T; Settakorn J
    Asian Pac J Cancer Prev; 2008; 9(4):653-7. PubMed ID: 19256755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis.
    Sağlam A; Usubütün A; Dolgun A; Mutter GL; Salman MC; Kurtulan O; Akyol A; Özkan EA; Baykara S; Bülbül D; Calay Z; Eren F; Gümürdülü D; Haberal N; Ilvan Ş; Karaveli Ş; Koyuncuoğlu M; Müezzinoğlu B; Müftüoğlu KH; Özen Ö; Özdemir N; Peştereli E; Ulukuş Ç; Zekioğlu O
    Turk Patoloji Derg; 2017; 1(1):177-191. PubMed ID: 28832077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Liu W; Gong J; Xu H; Zhang D; Xia N; Li H; Song K; Lv T; Chen Y; Diao Y; Jao J; Dai S; Zhao P; Yao Q
    Diagn Cytopathol; 2020 Jul; 48(7):635-644. PubMed ID: 32275355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.